Aurora Cannabis (ACB) Income towards Parent Company (2017 - 2026)

Aurora Cannabis (ACB) posted quarterly Income towards Parent Company of $4.4 million for Q1 2026, up 174.14% year-on-year from $1.6 million in Q1 2025, and down 98.85% on a QoQ basis from $384.6 million in Q4 2025.

Aurora Cannabis (ACB) Income towards Parent Company (2017 - 2026) Analysis & Trends

Aurora Cannabis (ACB) has reported Income towards Parent Company for 10 consecutive years, with $4.4 million the latest figure, recorded in Q1 2026.

  • Quarterly Income towards Parent Company rose 174.14% year-over-year to $4.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$548.6 million (up 48.66% YoY) and the FY2026 annual result came in at -$42.4 million, down 110.4% from the prior year.
  • Income towards Parent Company slipped to $4.4 million in Q1 2026 per ACB's latest filing, from $384.6 million in the prior quarter.
  • Over the last five years, Income towards Parent Company for ACB reached as high as $860.2 million in Q1 2022 and fell as low as -$545.4 million in Q4 2022.
  • A 5-year average of $186.1 million and a median of $375.8 million in 2023 frame the typical range for Income towards Parent Company.
  • Annual changes were most pronounced in 2022 — Income towards Parent Company sank 4195.43% — and 2026, when it surged 174.14%.
  • Year by year, Income towards Parent Company stood at -$545.4 million in 2022, then soared by 169.56% to $379.4 million in 2023, then climbed by 8.11% to $410.1 million in 2024, then decreased by 6.22% to $384.6 million in 2025, then slumped by 98.85% to $4.4 million in 2026.
  • According to Business Quant data, Income towards Parent Company over the past three periods registered $4.4 million, $384.6 million, and $386.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.28 Bn 87.42 Bn -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn
10 Aurora Cannabis 155.40 Mn 70.15 Mn 21.72 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.43 Mn
Dec 31, 2025 384.62 Mn
Sep 30, 2025 386.51 Mn
Jun 30, 2025 398.33 Mn
Mar 31, 2025 -5.97 Mn
Dec 31, 2024 410.12 Mn
Sep 30, 2024 398.17 Mn
Jun 30, 2024 410.62 Mn
Mar 31, 2024 -1.65 Mn
Dec 31, 2023 379.35 Mn
Sep 30, 2023 375.79 Mn
Jun 30, 2023 354.16 Mn
Mar 31, 2023 359.55 Mn
Dec 31, 2022 -545.38 Mn
Sep 30, 2022 -515.60 Mn
Jun 30, 2022 -488.98 Mn
Mar 31, 2022 860.20 Mn
Dec 31, 2021 1.55 Bn
Sep 30, 2021 -12.00 Mn
Jun 30, 2021 -87.26 Mn